These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3091241

  • 1. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
    Groos E, Walker L, Masters JR.
    Cancer; 1986 Sep 15; 58(6):1199-203. PubMed ID: 3091241
    [Abstract] [Full Text] [Related]

  • 2. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
    Groos E, Masters JR.
    J Urol; 1986 Aug 15; 136(2):399-402. PubMed ID: 3090275
    [Abstract] [Full Text] [Related]

  • 3. Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
    Walker MC, Masters JR, Parris CN, Hepburn PJ, English PJ.
    Urol Res; 1986 Aug 15; 14(3):137-40. PubMed ID: 3092427
    [Abstract] [Full Text] [Related]

  • 4. [Intravesical chemotherapy in superficial tumors of the bladder].
    Schulman CC.
    Arch Esp Urol; 1983 Aug 15; 36(1):32-40. PubMed ID: 6409013
    [No Abstract] [Full Text] [Related]

  • 5. Intravesical chemotherapy for superficial bladder cancer.
    Koontz WW.
    Urology; 1984 Apr 15; 23(4 Suppl):79-81. PubMed ID: 6424298
    [No Abstract] [Full Text] [Related]

  • 6. Intravesical chemotherapy of superficial bladder cancer.
    Lum BL.
    Recent Results Cancer Res; 1983 Apr 15; 85():3-36. PubMed ID: 6408716
    [No Abstract] [Full Text] [Related]

  • 7. Intravesical chemotherapy--frequency of instillation.
    Smith PH.
    Prog Clin Biol Res; 1985 Apr 15; 185B():57-68. PubMed ID: 3929271
    [No Abstract] [Full Text] [Related]

  • 8. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
    Seraphim LA, Perrapato SD, Slocum HK, Rustum YM, Huben RP.
    J Urol; 1991 Mar 15; 145(3):613-7. PubMed ID: 1900087
    [Abstract] [Full Text] [Related]

  • 9. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
    Mobley WC, Loening SA, Narayana AS, Culp DA.
    Urology; 1986 Apr 15; 27(4):335-9. PubMed ID: 3083555
    [Abstract] [Full Text] [Related]

  • 10. Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
    Parris CN, Masters JR, Walker MC, Newman B, Riddle P, English P.
    Urol Res; 1987 Apr 15; 15(1):17-20. PubMed ID: 3103302
    [Abstract] [Full Text] [Related]

  • 11. Treatment of superficial bladder cancer with intravesical chemotherapy.
    Badalament RA, Farah RN.
    Semin Surg Oncol; 1997 Apr 15; 13(5):335-41. PubMed ID: 9259089
    [Abstract] [Full Text] [Related]

  • 12. [Progress in the internist treatment of bladder tumors].
    Baumgartner G.
    Wien Med Wochenschr; 1982 Jul 31; 132(13-14):305-12. PubMed ID: 6814073
    [Abstract] [Full Text] [Related]

  • 13. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
    Knuchel R, Hofstadter F, Jenkins WE, Masters JR.
    Cancer Res; 1989 Mar 15; 49(6):1397-401. PubMed ID: 2493980
    [Abstract] [Full Text] [Related]

  • 14. Effects of interferon in combination with cytotoxic drugs on mouse bladder tumor (MBT-2) growth in vitro and in vivo.
    Bahnson R, Ratliff TL.
    J Urol; 1988 Sep 15; 140(3):656-9. PubMed ID: 2457714
    [Abstract] [Full Text] [Related]

  • 15. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS.
    Urol Clin North Am; 1984 Nov 15; 11(4):623-35. PubMed ID: 6438857
    [Abstract] [Full Text] [Related]

  • 16. Complications of intravesical chemotherapy.
    Thrasher JB, Crawford ED.
    Urol Clin North Am; 1992 Aug 15; 19(3):529-39. PubMed ID: 1636237
    [Abstract] [Full Text] [Related]

  • 17. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Aug 15; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 18. Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
    Smith G, Elton RA, Chisholm GD, Newsam JE, Hargreave TB.
    Br J Urol; 1986 Dec 15; 58(6):659-63. PubMed ID: 3099881
    [Abstract] [Full Text] [Related]

  • 19. Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro.
    Walker L, Walker MC, Parris CN, Masters JR.
    Urol Res; 1988 Dec 15; 16(4):329-31. PubMed ID: 3176208
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.